Targeting Amyloids with [<sup>18</sup>F]AV-45 for Medullary Thyroid Carcinoma Positron Emission Tomography/Computed Tomography Imaging: A Pilot Clinical Study

Chun Li(University of Southern California), Zhi Lu(St Thomas' Hospital), Zilin Yu(Jiangxi University of Traditional Chinese Medicine), PengXin Zhang(Dalian Medical University), Ruirui Nie(Dalian Medical University), Hua Zhang(Anhui Medical University), Chengdong Wang(Dalian Medical University), Jinghui Xie, Ran Yan(Dalian Medical University), Xiaoyan Gong(Society of Nuclear Medicine and Molecular Imaging)
Molecular Pharmaceutics
January 4, 2022
10.1021/acs.molpharmaceut.1c00680
Cited by 8

Related Papers

Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
|Nature Genetics|2010|680
Meta-analysis identifies common variants associated with body mass index in east Asians
|Nature Genetics|2012|405
Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic® F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization
|Journal of Controlled Release|2006|193
Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy
|International Journal of Biological Sciences|2024|165